Sipai Health Technology Co, Ltd
HKEX:314
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.08
8.03
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sipai Health Technology Co, Ltd
Cash & Cash Equivalents
Sipai Health Technology Co, Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sipai Health Technology Co, Ltd
HKEX:314
|
Cash & Cash Equivalents
¥495.4m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Cash & Cash Equivalents
¥2.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
LBX Pharmacy Chain JSC
SSE:603883
|
Cash & Cash Equivalents
¥768.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Cash & Cash Equivalents
¥3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
Cash & Cash Equivalents
¥829.9m
|
CAGR 3-Years
44%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Cash & Cash Equivalents
¥2.8B
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
8%
|
|
Sipai Health Technology Co, Ltd
Glance View
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company. The company is headquartered in Guangzhou, Guangdong and currently employs 3,269 full-time employees. The company went IPO on 2022-12-23. The Company’s businesses include Specialty Pharmacy Business, Physician Research Assistance Business and Health Insurance Services Business. Specialty Pharmacy Business includes the operation of offline specialty pharmacies and distribution of pharmaceutical products to pharmaceutical companies and other distributors. Physician Research Assistance Business mainly provides integrated services for pharmaceutical companies to assist them in producing clinical trial data that meets the relevant regulatory standards for the pharmaceutical companies to advance to the next phase of clinical or solicit approval of a treatment by the applicable regulatory body. Health Insurance Services Business provides insurance brokerage services including distribution of various health and life insurance products on behalf of insurance carriers.
See Also
What is Sipai Health Technology Co, Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
495.4m
CNY
Based on the financial report for Dec 31, 2023, Sipai Health Technology Co, Ltd's Cash & Cash Equivalents amounts to 495.4m CNY.
What is Sipai Health Technology Co, Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
-33%
Over the last year, the Cash & Cash Equivalents growth was -66%. The average annual Cash & Cash Equivalents growth rates for Sipai Health Technology Co, Ltd have been -33% over the past three years .
You don't have any saved screeners yet
